Vivos Therapeutics Adds AI-Powered Sleep Tech via SoundHealth Collaboration

  • Vivos Therapeutics has entered a collaboration with SoundHealth to distribute SoundHealth’s FDA-cleared allergy and sleep technologies.
  • Vivos will resell SoundHealth’s Sonu® Band and Spatial Sleep™ band through its network of over 2,000 dentists and sleep healthcare providers.
  • SoundHealth’s technology utilizes personalized vibro-acoustic neuromodulation and smartphone-based facial scanning and voice biomarker analysis.
  • The collaboration aims to leverage SoundHealth’s large craniofacial dataset to promote airway health awareness and treatment.

Vivos’ collaboration with SoundHealth represents a strategic move to expand its product offerings beyond its core CARE devices and capitalize on the growing $30 billion global sleep technology market. The partnership signals a broader trend toward personalized, AI-driven solutions in sleep apnea treatment, moving away from traditional, often less effective, methods like CPAP. SoundHealth’s FDA clearances and TIME ‘Best Inventions’ recognition provide a degree of validation, but the execution risk of integrating a new technology and distribution model into Vivos’ existing operations remains significant.

Market Adoption
The success of this collaboration hinges on Vivos’ ability to effectively integrate SoundHealth’s products into its existing provider network and drive patient adoption, given the relatively nascent stage of active airway intervention in sleep technology.
Data Integration
How Vivos utilizes SoundHealth’s craniofacial dataset and voice biomarker technology to improve diagnostic accuracy and treatment efficacy will be a key differentiator and a potential source of competitive advantage.
Regulatory Scrutiny
As the sleep technology sector shifts towards active interventions, increased regulatory scrutiny of device efficacy and patient safety is likely, which could impact the long-term viability of SoundHealth’s FDA-cleared devices.